Brief: GT Biopharma Announces Interim GTB-3550 Trike Monotherapy Clinical Trial Results
23/06/2021 13:47
June 23 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA ANNOUNCES INTERIM GTB-3550 TRIKE™ MONOTHERAPY
CLINICAL TRIAL RESULTS AT 2021 RAYMOND JAMES HUMAN HEALTH
INNOVATION CONFERENCE
* GT BIOPHARMA INC - 57% OF PATIENTS EXPERIENCED SIGNIFICANT
REDUCTION IN AML/MDS CANCER CELL BURDEN
* GT BIOPHARMA INC - UP TO 63.7% REDUCTION IN BONE MARROW
BLAST
LEVELS OBSERVED IN SOME PATIENTS
Source text for Eikon: ID:nPn23255Ra
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))